Anbio Biotechnology Stock Target Price and Analyst Consensus
| NNNN Stock | 34.99 2.51 7.73% |
Analysts of Anbio Biotechnology Class render investment recommendations by dissecting financials, analyzing earning calls, and talking to Anbio Biotechnology vendors, executives, and customers to validate their buy-or-sell advice. Unfortunately, the analyst consensus on Anbio Biotechnology is currently unavailable. Please use our comprehensive buy-or-sell advice module to check the latest Macroaxis investment opinion on Anbio Biotechnology
At this time, Anbio Biotechnology's Pretax Profit Margin is very stable compared to the past year. As of the 10th of January 2026, Operating Profit Margin is likely to grow to 0.42, while Gross Profit is likely to drop about 6.7 M. At this time, Anbio Biotechnology's Non Current Assets Total are very stable compared to the past year. As of the 10th of January 2026, Non Currrent Assets Other is likely to grow to about 467.8 K, while Total Assets are likely to drop about 14.7 M. It's important to approach Anbio Biotechnology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Anbio Biotechnology price targets
Anbio Biotechnology's stock target price is an estimate of its future price, usually made by analysts. Using Anbio Biotechnology's target price to determine if it is a suitable investment can be done through the following steps:- Look at Anbio Biotechnology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Anbio Biotechnology's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Anbio Biotechnology Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Anbio Biotechnology is a key component of Anbio Biotechnology valuation and have some predictive power on the future returns of a Anbio Biotechnology.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Social Domain Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Blockchain Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Momentum Invested over 30 shares | |
 | Cash Cows Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Chemicals Makers Invested over 70 shares | |
Check out Macroaxis Advice on Anbio Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.